ABSTRACT
Accumulating evidence suggests that physical activity may be beneficial in preserving cognition in late life. This study examined the association between baseline and changes in physical activity and cognitive decline in community-dwelling older people. Data were from the Korean Longitudinal Study of Aging, with 2605 aged 65 years and older subjects interviewed in 2006 and followed up for 2 years. Cognitive decline was defined by calculating the Reliable Change Index using the Mini-Mental State Examination. Physical activity levels were categorized as sedentary, low, or high. Changes in physical activity were classified as inactive, decreaser, increaser, or active. Logistic regression analysis of baseline and changes in physical activity with cognitive decline was performed. Compared with the sedentary group at baseline, both the low and high activity groups were less likely to experience cognitive decline. The active (odds ratio [OR] = 0.40, 95 % confidence interval [CI] 0.23-0.68) and increaser (OR = 0.45, 95 % CI 0.27-0.74) group, compared with the inactive counterpart, demonstrated a significantly lower likelihood of cognitive decline. Older adults who remained active or increased activity over time had a reduced risk of cognitive decline. Engagement in physical activity in late life may have cognitive health benefits.
Subject(s)
Cognitive Aging , Motor Activity , Aged , Alcohol Drinking , Body Mass Index , Cognitive Aging/physiology , Female , Humans , Male , Motor Activity/physiology , Sedentary Behavior , Socioeconomic FactorsABSTRACT
BACKGROUND: Frailty and body mass index (BMI) are known to be predictive of late life mortality, but little is known about the combined effects of frailty and BMI on mortality. OBJECTIVE: This study investigated the influence of frailty status and BMI category on mortality in older adults. METHODS: Data were from the Living Profiles of Older People Survey, a national survey of community-dwelling older people in Korea, with a baseline study of 11,844 Koreans aged 65 years and older in 2008 and a 3-year follow-up for mortality. Frailty was categorized as not frail, prefrail, and frail, based on five indicators (weight loss, exhaustion, physical activity, walking speed, and grip strength). BMI (kg/m(2)) was classified as underweight (<18.5), normal (18.5-24.9), overweight (25.0-29.9), or obese (≥30.0). A Cox proportional model was used to analyze the association of the combined frailty and BMI categories with all-cause mortality, adjusting for sociodemographics and health-related factors. RESULTS: Adjusting for covariates, compared with the normal-weight nonfrail counterpart, the underweight or normal-weight prefrail/frail status demonstrated significantly increased rates of death. The obese frail respondents showed a significantly higher mortality risk (hazard ratio, 3.89; 95% confidence interval, 1.14-13.28). The overweight prefrail/frail group, however, exhibited no significant association with mortality. CONCLUSION: Among older people who were of normal weight or underweight, greater frailty was associated with poorer survival. Whereas being overweight tended to be neutral of the influence of frailty on mortality, the obese frail exhibited a significantly elevated rate of death.
Subject(s)
Body Mass Index , Frail Elderly , Health Status , Obesity/mortality , Residence Characteristics , Thinness/mortality , Aged , Aged, 80 and over , Cohort Studies , Female , Health Surveys , Humans , Male , Predictive Value of Tests , Proportional Hazards Models , Republic of Korea , Risk Factors , Socioeconomic Factors , Survival RateABSTRACT
BACKGROUND: Frailty is highly prevalent in older people, but its association with cognitive function is poorly understood. The aim of this study was to examine the association between cognitive function and frailty in community-dwelling older adults. METHODS: Data were from the 2008 Living Profiles of Older People Survey, comprising 10,388 nationally representative sample aged 65 years and older living in the community in South Korea. Frailty criteria included unintentional weight loss, exhaustion, weakness, low physical activity, and slow walking speed. Cognitive function was assessed using the Korean version of the Mini-Mental State Examination. Multinomial logistic regression models were constructed with frailty status regressed on cognitive impairment and subdomains of cognitive function, adjusting for covariates. RESULTS: Those who were frail showed a higher percentage of cognitive impairment (55.8% in men, 35.2% in women) than those who were not (22.1% in men, 15.6% in women). Cognitive impairment was associated with an increased risk of frailty in men (odds ratio (OR) = 1.81, 95% confidence interval (CI): 1.25-2.60) and women (OR = 1.69, 95% CI: 1.25-2.30) even after controlling for all covariates. Among the subdomains of cognitive function, time orientation, registration, attention, and judgment were associated with a lower likelihood of frailty in both men and women after adjusting for confounders. Among women higher scores on recall, language components, and visual construction were also significantly associated with lower odds of frailty. CONCLUSIONS: Cognitive impairment was associated with a higher likelihood of frailty in community-dwelling older men and women. Total scores and specific subdomains of cognitive function were inversely associated with frailty.
Subject(s)
Cognitive Dysfunction/epidemiology , Frail Elderly/psychology , Activities of Daily Living/psychology , Aged , Cognitive Dysfunction/psychology , Female , Frail Elderly/statistics & numerical data , Geriatric Assessment , Humans , Logistic Models , Male , Neuropsychological Tests , Republic of Korea/epidemiologyABSTRACT
Defects in mitochondrial function have been shown to participate in the induction of cell death in cancer cells. The present study was designed to assess the toxic effect of 18beta-glycyrrhetinic acid against human cervix and uterus tumor cell line SiHa cells in relation to the mitochondria-mediated cell-death process and evaluate the combined toxic effect of 18beta-glycyrrhetinic acid and anti-cancer drugs. 18beta-Glycyrrhetinic acid induced the nuclear damage, changes in the mitochondrial membrane permeability, formation of reactive oxygen species and depletion of glutathione in SiHa cells. It caused cell death by inducing the increase in the pro-apoptotic Bax protein and cytochrome c levels, reduction in anti-apoptotic Bcl-2 level, subsequent caspase-3 activation and loss of the mitochondrial transmembrane potential. Unlike 18beta-glycyrrhetinic acid, a pro-compound glycyrrhizin up to 100 microM did not induce cell death and depletion of glutathione. Combined treatment of mitomycin c (or doxorubicin) and 18beta-glycyrrhetinic acid revealed a synergistic toxic effect. Meanwhile, combination of camptothecin and 18beta-glycyrrhetinic acid exhibited an additive cytotoxic effect. Results suggest that 18beta-glycyrrhetinic acid may cause cell death in SiHa cells by inducing the mitochondrial membrane permeability change, leading to cytochrome c release and caspase-3 activation. The effect may be associated with increased formation of reactive oxygen species and depletion of glutathione. Combined treatment of antibiotic anti-cancer drug and 18beta-glycyrrhetinic acid seems to exhibit a synergistic toxic effect.
Subject(s)
Antibiotics, Antineoplastic/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Glycyrrhetinic Acid/analogs & derivatives , Uterine Cervical Neoplasms/drug therapy , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Combinations , Drug Screening Assays, Antitumor , Drug Synergism , Female , Glutathione/metabolism , Glycyrrhetinic Acid/pharmacology , Humans , Mitochondrial Membranes/drug effects , Permeability/drug effects , Reactive Oxygen Species/metabolism , Uterine Cervical Neoplasms/metabolism , Uterine Cervical Neoplasms/pathologyABSTRACT
The present study was designed to assess the preventive effect of licorice compounds glycyrrhizin and 18beta-glycyrrhetinic acid against mitochondrial damage and cell death in lung epithelial cells exposed to 3-morpholinosydnonime, a donor of nitric oxide and superoxide. Treatment of lung epithelial cells with 3-morpholinosydnonime resulted in the nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species and depletion of GSH. Treatment of glycyrrhizin and 18beta-glycyrrhetinic acid attenuated the 3-morpholinosydnonime-induced mitochondrial damage, formation of reactive oxygen species and GSH depletion and revealed a maximal inhibitory effect at 10 and 1 muM, respectively; beyond these concentrations the inhibitory effect declined. Melatonin, carboxy-PTIO, rutin and uric acid reduced the 3-morpholinosydnonime-induced cell death. The results show that glycyrrhizin and 18beta-glycyrrhetinic acid seem to prevent the toxic effect of 3-morpholinosydnonime against lung epithelial cells by suppressing the mitochondrial permeability transition that leads to the release of cytochrome c and activation of caspase-3. The preventive effect may be ascribed to the inhibitory action on the formation of reactive oxygen species and depletion of GSH. The findings suggest that licorice compounds seem to prevent the nitrogen species-mediated lung cell damage.
Subject(s)
Cytoprotection , Epithelial Cells/drug effects , Glycyrrhizic Acid/pharmacology , Lung/drug effects , Molsidomine/analogs & derivatives , Nitric Oxide Donors/antagonists & inhibitors , Apoptosis/drug effects , Humans , Lung/cytology , Mitochondria/drug effects , Mitochondrial Membranes/drug effects , Molsidomine/antagonists & inhibitors , Molsidomine/toxicity , Nitric Oxide Donors/toxicity , Oxidative Stress/drug effects , Permeability/drug effectsABSTRACT
Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the effect of antiepileptic lamotrigine against the cytotoxicity of mitochondrial respiratory complex I inhibitors rotenone and 1-methyl-4-phenylpyridinium (MPP+) in relation to the mitochondria-mediated cell death process and oxidative stress. Both rotenone and MPP+ induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in differentiated PC12 cells. Lamotrigine significantly attenuated the rotenone- or MPP+-induced mitochondrial damage leading to caspase-3 activation, increased oxidative stress and cell death. The preventive effect of lamotrigine against the toxicity of rotenone was greater than its effect on that of MPP+. The results show that lamotrigine seems to reduce the cytotoxicity of rotenone and MPP+ by suppressing the mitochondrial permeability transition formation, leading to cytochrome c release and subsequent activation of caspase-3. The preventive effect may be ascribed to its inhibitory action on the formation of reactive oxygen species and depletion of GSH. Lamotrigine seems to exert a protective effect against the neuronal cell injury due to the mitochondrial respiratory complex I inhibition.
Subject(s)
Cell Death/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/drug effects , Neurons/metabolism , Neurotoxins/antagonists & inhibitors , Triazines/pharmacology , 1-Methyl-4-phenylpyridinium/antagonists & inhibitors , 1-Methyl-4-phenylpyridinium/toxicity , Animals , Apoptosis/drug effects , Apoptosis/physiology , Caspase 3/drug effects , Caspase 3/metabolism , Cell Death/physiology , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/physiology , Cytochromes c/metabolism , Electron Transport Complex I/antagonists & inhibitors , Electron Transport Complex I/metabolism , Enzyme Activation/drug effects , Enzyme Activation/physiology , Excitatory Amino Acid Antagonists/pharmacology , Glutathione/metabolism , Lamotrigine , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/physiology , Nerve Degeneration/drug therapy , Nerve Degeneration/metabolism , Nerve Degeneration/prevention & control , Oxidative Stress/drug effects , Oxidative Stress/physiology , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Rotenone/antagonists & inhibitors , Rotenone/toxicityABSTRACT
Oxysterols such as 7-ketocholesterol and 25-hydroxycholesterol formed under enhanced oxidative stress in the brain are suggested to induce neuronal cell death. The present study investigated the effect of calmodulin antagonists (trifluoperazine, W-7 and calmidazolium) against the cytotoxicity of 7-ketocholesterol in relation to the mitochondria-mediated cell death process and oxidative stress. PC12 cells exposed to 7-ketocholesterol revealed nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species and depletion of GSH. N-Acetylcysteine, trolox, carboxy-PTIO and Mn-TBAP reduced the cytotoxic effect of 7-ketocholesterol. Calmodulin antagonists attenuated the 7-ketocholesterol-induced nuclear damage, formation of the mitochondrial permeability transition and cell viability loss in PC12 cells. The results suggest that calmodulin antagonists may prevent the 7-ketocholesterol-induced viability loss in PC12 cells by suppressing formation of the mitochondrial permeability transition, leading to the release of cytochrome c and subsequent activation of caspase-3. The effects seem to be ascribed to their depressant action on the formation of reactive oxygen species and depletion of GSH. The findings suggest that calmodulin inhibition may exhibit a protective effect against the neurotoxicity of 7-ketocholesterol.
Subject(s)
Calmodulin/metabolism , Enzyme Inhibitors/pharmacology , Ketocholesterols/pharmacology , Mitochondria/drug effects , Animals , Caspase 3/metabolism , Cell Death/drug effects , Cell Survival/drug effects , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Activation/drug effects , Flow Cytometry , Glutathione/metabolism , Mitochondrial Membranes/drug effects , Oxidative Stress/drug effects , PC12 Cells/drug effects , Permeability/drug effects , Rats , Reactive Oxygen Species/metabolismABSTRACT
The present study assessed the influence of intracellular Ca2+ and calmodulin against the neurotoxicity of oxysterol 7-ketocholesterol in relation to the mitochondria-mediated cell death process and oxidative stress in PC12 cells. Calmodulin antagonists calmidazolium and W-7 prevented the 7-ketocholesterol-induced mitochondrial damage, leading to caspase-3 activation and cell death, whereas Ca2+ channel blocker nicardipine, mitochondrial Ca2+ uptake inhibitor ruthenium red, and cell permeable Ca2+ chelator BAPTA-AM did not reduce it. Exposure of PC12 cells to 7-ketocholesterol caused elevation of intracellular Ca2+ levels. Unlike cell injury, calmodulin antagonists, nicardipine, and BAPTA-AM prevented the 7-ketocholesterol-induced elevations of intracellular Ca2+ levels. The results show that the cytotoxicity of 7-ketocholesterol seems to be modulated by calmodulin rather than changes in intracellular Ca2+ levels. Calmodulin antagonists may prevent the cytotoxicity of 7-ketocholesterol by suppressing the mitochondrial permeability transition formation, which is associated with the increased formation of reactive oxygen species and the depletion of GSH.
Subject(s)
Calcium Channel Blockers/pharmacology , Calmodulin/antagonists & inhibitors , Ketocholesterols/toxicity , PC12 Cells/drug effects , Animals , Apoptosis/drug effects , Calcium/physiology , Calmodulin/physiology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Imidazoles/pharmacology , Ketocholesterols/antagonists & inhibitors , Mitochondrial Membranes/drug effects , Nicardipine/pharmacology , Permeability/drug effects , Rats , Ruthenium Red/pharmacology , Sulfonamides/pharmacology , Verapamil/pharmacologyABSTRACT
1-Methyl-4-phenylpyridinium (MPP(+)) or 6-hydroxydopamine (6-OHDA) caused a nuclear damage, the mitochondrial membrane permeability changes, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in PC12 cells. Nicardipine (a calcium channel blocker), EGTA (an extracellular calcium chelator), BAPTA-AM (a cell permeable calcium chelator) and calmodulin antagonists (W-7 and calmidazolium) attenuated the MPP(+)-induced mitochondrial damage and cell death. In contrast, the compounds did not reduce the toxicity of 6-OHDA. Treatment with MPP(+ )or 6-OHDA evoked the elevation of intracellular Ca(2+) levels. Unlike cell injury, addition of nicardipine, BAPTA-AM and calmodulin antagonists prevented the elevation of intracellular Ca(2+) levels due to both toxins. The results show that the MPP(+)-induced formation of the mitochondrial permeability transition seems to be mediated by elevation of intracellular Ca(2+) levels and calmodulin action. In contrast, the 6-OHDA-induced cell death seems to be mediated by Ca(2+)-independent manner.
Subject(s)
1-Methyl-4-phenylpyridinium/pharmacology , Calcium/metabolism , Cell Death/drug effects , Oxidopamine/pharmacology , Animals , Calmodulin/antagonists & inhibitors , Chelating Agents/pharmacology , Cytochromes c/metabolism , Egtazic Acid/administration & dosage , Egtazic Acid/analogs & derivatives , Glutathione/metabolism , Mitochondria/drug effects , Mitochondria/metabolism , Nicardipine/administration & dosage , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Sulfonamides/pharmacologyABSTRACT
Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The effect of econazole against the cytotoxicity of 1-methyl-4-phenylpyridinium (MPP(+)) in differentiated PC12 cells was assessed in relation to the mitochondrial membrane permeability changes. Treatment of PC12 cells with MPP(+) resulted in the nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species (ROS) and depletion of GSH. Econazole (0.25-2.5 microM) inhibited the cytotoxicity of MPP(+) or rotenone. The addition of econazole (0.5 microM) significantly attenuated the MPP(+)-induced mitochondrial damage, elevation of intracellular Ca(2+) level and cell death. However, because of the cytotoxicity, econazole at 5 microM did not attenuate the toxicity of MPP(+). The results show that econazole at the low concentrations may reduce the MPP(+)-induced viability loss in PC12 cells by suppressing the mitochondrial permeability transition, leading to activation of caspase-3 and the elevation of intracellular Ca(2+) levels, which are associated with the increased formation of ROS and depletion of GSH.
Subject(s)
1-Methyl-4-phenylpyridinium/toxicity , Econazole/pharmacology , Herbicides/toxicity , Mitochondrial Membranes/drug effects , Animals , Apoptosis/drug effects , Calcium/metabolism , Caspase 3 , Caspases/metabolism , Cell Survival/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Flow Cytometry/methods , Membrane Potentials/drug effects , PC12 Cells/ultrastructure , Permeability/drug effects , Rats , Reactive Oxygen Species/metabolismABSTRACT
The effect of alkaloid piperine against the toxicity of 1-methyl-4-phenylpyridinium (MPP(+)) in differentiated PC12 cells was assessed. Piperine treatment revealed a differential effect on the cytotoxicity of MPP(+) and had its maximum inhibitory effect at 1 microM. The addition of piperine (0.5-10 microM) significantly reduced the MPP(+)-induced nuclear damage, mitochondrial membrane permeability changes, formation of reactive oxygen species and depletion of GSH. In contrast, piperine at 50-100 microM showed cytotoxicity and exhibited an additive effect against the MPP(+) toxicity. The results indicate that piperine had a differential effect on the cytotoxicity of MPP(+) depending on concentration. Piperine at low concentrations may reduce the MPP(+)-induced viability loss in PC12 cells by suppressing the changes in the mitochondrial membrane permeability, leading to the release of cytochrome c and subsequent activation of caspase-3. The effects may be ascribed to its inhibitory action on the formation of reactive oxygen species and depletion of GSH.
Subject(s)
1-Methyl-4-phenylpyridinium/toxicity , Alkaloids/pharmacology , Mitochondria/drug effects , Mitochondrial Membranes/drug effects , Piperidines/pharmacology , Animals , Benzodioxoles , Caspase 3 , Caspases/biosynthesis , Cell Death/drug effects , Cell Membrane Permeability/drug effects , Cytochromes c/biosynthesis , DNA Fragmentation , Glutathione/metabolism , Lipid Peroxidation/drug effects , Malondialdehyde/metabolism , Membrane Potentials/drug effects , Mitochondria/physiology , Mitochondrial Membranes/physiology , PC12 Cells , Polyunsaturated Alkamides , Rats , Reactive Oxygen Species/metabolism , Thiobarbituric Acid Reactive Substances/metabolismABSTRACT
Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the influence of the mitochondrial membrane permeability transition inhibition against the toxicity of 1-methyl-4-phenylpyridinium (MPP(+)) and 6-hydroxydopamine (6-OHDA) in relation to the mitochondria-mediated cell death process and role of oxidative stress. Both MPP(+) and 6-OHDA induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in differentiated PC12 cells. Cyclosporin A (CsA), trifluoperazine and aristolochic acid, inhibitors of mitochondrial permeability transition, significantly attenuated the MPP(+)-induced mitochondrial damage leading to caspase-3 activation, increased oxidative stress and cell death. In contrast to MPP(+), the cytotoxicity of 6-OHDA was not reduced by the addition of the mitochondrial permeability transition inhibitors. The results show that the cytotoxicity of MPP(+) may be mediated by the mitochondrial permeability transition formation, which is associated with formation of reactive oxygen species and the depletion of GSH. In contrast, the 6-OHDA-induced cell injury appears to be mediated by increased oxidative stress without intervention of the mitochondrial membrane permeability transition.
Subject(s)
1-Methyl-4-phenylpyridinium/toxicity , Hydroxydopamines/toxicity , Mitochondrial Membranes/drug effects , Animals , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , Cyclosporine/pharmacology , Cytochrome c Group/metabolism , Glutathione/metabolism , Mitochondrial Membranes/metabolism , PC12 Cells , Permeability/drug effects , Rats , Reactive Oxygen Species/metabolism , Trifluoperazine/pharmacologyABSTRACT
The present study investigates the effect of sulfonylurea glibenclamide on the cytotoxicity of 1-methyl-4-phenylpyridinium (MPP+) in differentiated PC12 cells in relation to changes in the mitochondrial membrane permeability. Glibenclamide and tolbutamide reduced the MPP+-induced cell death and GSH depletion concentration dependently with a maximal inhibitory effect at 5-10 microM. Despite the toxic effect at 20 microM, sulfonylureas showed an inhibitory effect. N-Acetylcysteine, superoxide dismutase, catalase, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and Mn(III) tetrakis(4-benzoic acid)porphyrin chloride inhibited the cytotoxicity of MPP+. Glibenclamide attenuated the nuclear damage, changes in the mitochondrial membrane permeability, caspase-3 activation and formation of reactive oxygen species due to MPP+ in PC12 cells. The results show that glibenclamide may reduce the MPP+-induced viability loss in PC12 cells by suppressing the changes in the mitochondrial membrane permeability, leading to the release of cytochrome c and subsequent activation of caspase-3, which are associated with the increased reactive oxygen species formation and depletion of GSH.
Subject(s)
Apoptosis/drug effects , Glyburide/pharmacology , Mitochondrial Membranes/drug effects , 1-Methyl-4-phenylpyridinium/toxicity , Acetylcysteine/pharmacology , Animals , Benzoates/pharmacology , Caspase 3 , Caspases/metabolism , Catalase/pharmacology , Cell Nucleus/drug effects , Cell Nucleus/physiology , Cell Survival/drug effects , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Glutathione/antagonists & inhibitors , Glutathione/deficiency , Glutathione/metabolism , Imidazoles/pharmacology , Mitochondrial Membranes/physiology , PC12 Cells , Permeability/drug effects , Porphyrins/pharmacology , Rats , Reactive Oxygen Species/metabolism , Tolbutamide/pharmacologyABSTRACT
The addition of rotenone (inhibitor of respiratory complex I), 3-nitropropionic acid (complex II inhibitor), harmine (inhibitor of complexes I and II) and cyclosporin A (CsA, an inhibitor of the mitochondrial permeability transition) reduced the nuclear damage, loss in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species and depletion of GSH in differentiated PC12 cells treated with MG132, a proteasome inhibitor. Meanwhile, rotenone, 3-nitropropionic acid and harmine did not affect the inhibitory effect of CsA or trifluoperazine (an inhibitor of the mitochondrial permeability transition and calmodulin antagonist) on the cytotoxicity of MG132. The results suggest that proteasome inhibition-induced mitochondrial dysfunction and cell injury may be attenuated by the inhibitions of respiratory chain complex I and II. The cytoprotective effect of the mitochondrial permeability transition prevention not appears to be modulated by respiratory complex inhibition.
Subject(s)
Cell Death/physiology , Electron Transport/physiology , Enzyme Inhibitors/metabolism , Mitochondria/metabolism , Proteasome Inhibitors , Animals , Cell Membrane Permeability , Cyclosporine/metabolism , Glutathione/metabolism , Harmine/metabolism , Humans , Leupeptins/metabolism , Nitro Compounds/metabolism , PC12 Cells , Propionates/metabolism , Rats , Reactive Oxygen Species/metabolism , Rotenone/metabolism , Trifluoperazine/metabolism , Uncoupling Agents/metabolismABSTRACT
Defects in proteasome function have been suggested to be involved in the pathogenesis of neurodegenerative diseases. We examined the effect of calmodulin antagonists on proteasome inhibitor-induced mitochondrial dysfunction and cell viability loss in undifferentiated PC12 cells. Caspase inhibitors (z-IETD.fmk, z-LEHD.fmk and z-DQMD.fmk) and antioxidants attenuated cell death and decrease in GSH contents in PC12 cells treated with 20 microM MG132, a proteasome inhibitor. Calmodulin antagonists (trifluoperazine, W-7 and calmidazolium) had a differential inhibitory effect on the MG132-induced cell death and GSH depletion depending on concentration with a maximal inhibitory effect at 0.5-1 microM. Addition of trifluoperazine and W-7 reduced the MG132-induced nuclear damage, loss of the mitochondrial transmembrane potential followed by cytochrome c release, formation of reactive oxygen species and elevation of intracellular Ca(2+) levels in PC12 cells. Calmodulin antagonists at 5 microM exhibited a cytotoxic effect on PC12 cells but attenuated the cytotoxicity of MG132. The results suggest that the toxicity of MG132 on PC12 cells is mediated by activation of caspase-8, -9 and -3. Trifluoperazine and W-7 at the concentrations of 0.5-1 microM may attenuate the MG132-induced viability loss in PC12 cells by suppressing change in the mitochondrial membrane permeability and by lowering of the intracellular Ca(2+) levels as well as calmodulin inhibition.
Subject(s)
Calmodulin/agonists , Enzyme Inhibitors/pharmacology , Imidazoles/pharmacology , Leupeptins , Mitochondrial Diseases/prevention & control , Animals , Calcium/metabolism , Caspase 3 , Caspases/metabolism , Cell Count/methods , Cell Death/drug effects , Cell Size/drug effects , Cell Survival/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Drug Interactions , Glutathione/metabolism , Mitochondrial Diseases/chemically induced , PC12 Cells , Rats , Reactive Oxygen Species/metabolism , Sulfonamides/pharmacology , Trifluoperazine/pharmacologyABSTRACT
The promoting effect of ethanol against the cytotoxicity of hydrogen peroxide (H2O2) in differentiated PC12 cells was assessed by measuring the effect on the mitochondrial membrane permeability. Treatment of PC12 cells with H2O2 resulted in the nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species (ROS) and depletion of GSH. In PC12 cells and dopaminergic neuroblastoma SH-SY5Y cells, the promoting effect of ethanol on the H2O2-induced cell death was increased with exposure time. Ethanol promoted the nuclear damage, change in the mitochondrial membrane permeability, ROS formation and decrease in GSH contents due to H2O2 in PC12 cells. Catalase, carboxy-PTIO, Mn-TBAP, N-acetylcysteine, cyclosporin A and trifluoperazine inhibited the H2O2 and ethanol-induced mitochondrial dysfunction and cell injury. The results show that the ethanol treatment promotes the cytotoxicity of H2O2 against PC12 cells. Ethanol may enhance the H2O2-induced viability loss in PC12 cells by promoting the mitochondrial membrane permeability change, release of cytochrome c and subsequent activation of caspase-3, which is associated with the increased formation of ROS and depletion of GSH. The findings suggest that ethanol as a promoting agent for the formation of mitochondrial permeability transition may enhance the neuronal cell injury caused by oxidants.
Subject(s)
Ethanol/pharmacology , Hydrogen Peroxide/pharmacology , Intracellular Membranes/drug effects , Mitochondria/drug effects , Animals , Cell Survival/drug effects , Cell Survival/physiology , Dose-Response Relationship, Drug , Drug Synergism , Intracellular Membranes/physiology , Membrane Potentials/physiology , Mitochondria/metabolism , PC12 Cells , Permeability/drug effects , RatsABSTRACT
The effect of 3-morpholinosydnonimine (SIN-1) against the cytotoxicity of MG132, a proteasome inhibitor, in differentiated PC12 cells was assessed by measuring the effect on the mitochondrial membrane permeability. Treatment of PC12 cells with MG132 resulted in the nuclear damage, decrease in the mitochondrial transmembrane potential, cytosolic accumulation of cytochrome c, activation of caspase-3, increase in the formation of reactive oxygen species (ROS), and depletion of GSH. Addition of SIN-1, a producer of nitric oxide (NO) and superoxide, differentially reduced the MG132-induced cell death and GSH depletion concentration dependently with a maximal inhibitory effect at 150 microM. Carboxy-PTIO, superoxide dismutase, Mn-TBAP, and ascorbate prevented the inhibitory effect of SIN-1 on the cytotoxicity of MG132. SIN-1 inhibited the MG132-induced change in the mitochondrial membrane permeability, ROS formation and decrease in GSH contents in PC12 cells. S-nitroso-N-acetyl-DL-penicillamine reduced the MG132-induced cell death in PC12 cells, whereas peroxynitrite and H2O2 did not affect the cytotoxicity of MG132. The results suggest that NO and superoxide liberated from SIN-1 exert an inhibitory effect against the cytotoxicity of MG132. SIN-1 may inhibit the MG132-induced viability loss in PC12 cells by suppressing change in the mitochondrial membrane permeability that is associated with oxidative damage.
Subject(s)
Energy Metabolism/physiology , Leupeptins/antagonists & inhibitors , Mitochondria/metabolism , Molsidomine/analogs & derivatives , Molsidomine/pharmacology , Nitric Oxide/antagonists & inhibitors , Oxidative Stress/physiology , Animals , Antioxidants/pharmacology , Cell Death/drug effects , Cell Death/physiology , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/physiology , Cysteine Proteinase Inhibitors/toxicity , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Energy Metabolism/drug effects , Enzyme Inhibitors/pharmacology , Free Radicals/metabolism , Glutathione/metabolism , Leupeptins/toxicity , Mitochondria/drug effects , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Oxidative Stress/drug effects , PC12 Cells , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Rats , Superoxides/metabolismABSTRACT
Opening of the mitochondrial permeability transition pore has been recognized to be involved in cell death. The present study investigated the effect of trifluoperazine and W-7 on the MPP+-induced mitochondrial damage and cell death in undifferentiated PC12 cells. Calmodulin antagonists (trifluoperazine, W-7 and calmidazolium) at 0.5-1 microM significantly reduced the loss of cell viability in PC12 cells treated with 500 microM MPP+. Trifluoperazine and W-7 (0.5-1 microM) inhibited the nuclear damage, the loss of the mitochondrial transmembrane potential followed by cytochrome c release, and the elevation of intracellular Ca2+ levels due to MPP+ in PC12 cells and attenuated the formation of reactive oxygen species and the depletion of GSH. Calmodulin antagonists at 5-10 microM exhibited a cytotoxic effect on PC12 cells, and compounds at 10 microM did not attenuate cytotoxicity of MPP+. Calmodulin antagonists (0.5-1 microM) significantly reduced rotenone-induced mitochondrial damage and cell death, whereas they did not attenuate cell death and elevation of intracellular Ca2+ levels due to H2O2 or ionomycin. The results show that trifluoperazine and W-7 exhibit a differential inhibitory effect against cytotoxicity of MPP+ depending on concentration. Both compounds at the concentrations less than 5 microM may attenuate the MPP+-induced viability loss in PC12 cells by suppressing change in the mitochondrial membrane permeability and by lowering the intracellular Ca2+ levels.
Subject(s)
Antipsychotic Agents/pharmacology , Enzyme Inhibitors/pharmacology , Mitochondria/drug effects , Pyridinium Compounds/antagonists & inhibitors , Pyridinium Compounds/toxicity , Sulfonamides/pharmacology , Trifluoperazine/pharmacology , Animals , Calcium/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calmodulin/antagonists & inhibitors , Caspase 3 , Caspases/metabolism , Cell Death/drug effects , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Flow Cytometry , Glutathione/metabolism , Indicators and Reagents , PC12 Cells , Permeability , Rats , Reactive Oxygen Species/metabolism , Rotenone/pharmacologyABSTRACT
The present study investigated the effect of 1-methylated beta-carbolines (harmaline, harmalol and harmine) on change in the mitochondrial membrane permeability and cell death due to reactive nitrogen species in differentiated PC12 cells. beta-Carbolines, caspase inhibitors (z-LEHD.fmk and z-DQMD.fmk) and antioxidants (N-acetylcysteine, dithiothreitol, melatonin, carboxy-PTIO and uric acid) depressed cell viability loss due to 3-morpholinosydnonimine (SIN-1) in PC12 cells. beta-Carbolines inhibited the nuclear damage, the decrease in mitochondrial transmembrane potential, the cytochrome c release, the formation of reactive oxygen species and the depletion of GSH caused by SIN-1 in PC12 cells. beta-Carbolines decreased the SIN-1-induced formations of 3-nitrotyrosine, malondialdehyde and carbonyls in PC12 cells. The results show that 1-methylated beta-carbolines attenuate SIN-1-induced mitochondrial damage. This results in the inhibition of caspase-9 and -3 and apoptotic cell death in PC12 cells by suppressing the toxic actions of reactive oxygen and nitrogen species, including the GSH depletion.
Subject(s)
Carbolines/pharmacology , Mitochondria/drug effects , Molsidomine/analogs & derivatives , Molsidomine/toxicity , Animals , Carbolines/chemistry , Cell Survival/drug effects , Cell Survival/physiology , Mitochondria/metabolism , Molsidomine/antagonists & inhibitors , PC12 Cells , RatsABSTRACT
The effect of GSH depletion on mitochondrial damage and cell death due to mitomycin c (MMC) was assessed in small cell lung cancer (SCLC) cells. Cytotoxicity of MMC was attenuated by Tempol and dicumarol, inhibitors of the enzymatic reduction, and increased by xanthine oxidase. The MMC-induced cell death and decrease in the GSH contents in SCLC cells were inhibited by caspase inhibitors (z-DQMD.fmk, z-IETD.fmk and z-LEHD.fmk) and antioxidants (N-acetylcysteine, dithiothreitol and N-(2-mercaptopropionyl)glycine, melatonin, rutin and carboxy-PTIO). Thiol compounds, melatonin and rutin attenuated the MMC-induced nuclear damage, decrease in mitochondrial transmembrane potential, release of cytochrome c and activation of caspase-3. Treatment of MMC caused a significant decrease in GSH contents in SCLC cells, which was followed by increase in the formation of reactive oxygen species. Depletion of GSH due to L-buthionine sulfoximine enhanced the MMC-induced activation of caspase-3 and cell death in SCLC cells. Antioxidants, including N-acetylcysteine, depressed formations of nitric oxide, malondialdehyde and carbonyls due to MMC in SCLC cells. The results show that the reductive activation of MMC may cause cell death in SCLC cells by inducing mitochondrial dysfunction, leading to caspase-3 activation, and by activation of caspase-8. The MMC-induced change in the mitochondrial membrane permeability, followed by cell death, in SCLC cells may be significantly enhanced by decrease in the intracellular GSH contents due to oxidative attack of free radicals.